Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma

BACKGROUND: Current guidelines lack recommendations for the use of immunotherapy and immune-related biomarkers for hepatocellular carcinoma (HCC). We aim to provide reliable evidence of the association of survival with HCC immunotherapy and to demonstrate that genomic mutation signature could be an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Ou, Qiyun, Yu, Yunfang, Li, Anlin, Chen, Jie, Yu, Tingting, Xu, Xiaolin, Xie, Xinxin, Chen, Yongjian, Lin, Dagui, Zeng, Qiaohong, Zhang, Yuxin, Tang, Xudong, Yao, Herui, Luo, Baoming
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154492/
https://ncbi.nlm.nih.gov/pubmed/32309377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.01.32
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares